Insider at Avexis (AVXS) Makes Significant Sale of Stock

Wednesday, October 11, 2017 10:15 PM ET

Insider at Avexis (AVXS) Makes Significant Sale of Stock

A SEC filing today revealed a notable insider sale of Avexis shares as — Brian K. Kaspar, 10% Owner, Director and Officer — sold 15,000 shares in the company having a market value of approximately $1,521,843. This is the first insider buy/sell trade in the past 90 days.

Avexis buy-sell trading activity is close to the 264 member peer company average. The Bio Therapeutic Drugs peer group saw 317 buy/sell trades during this period for an average of 1.2 transactions per company. However, trading at Avexis represents a lower number of shares per transaction. Within the peer group there were 8,927,126 shares purchased and 20,543,190 shares sold with company insiders having sold 36,644 shares on average over this time period.

For the purpose of evaluating significant insider buying and selling all trades reported to the SEC that involve awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers have been eliminated in data obtained to compose and write this story.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2017 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.